Cash & equivalents increased 84.6%
Cash & equivalents changed +84.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$125.4M→$231.4M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CXM financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 48.3%
Free-cash-flow proxy changed -48.3% from the comparable as-filed period.
$34.4M→$17.8M3 prior comparisons
Gross margin moved 307 bp lower
Gross margin changed -307 basis points from the comparable as-filed period.
68.20%→65.12%2 prior comparisons
Operating cash flow decreased 47.8%
Operating cash flow changed -47.8% from the comparable as-filed period.
$34.8M→$18.2M3 prior comparisons
Operating margin moved 302 bp lower
Operating margin changed -302 basis points from the comparable as-filed period.
7.67%→4.66%2 prior comparisons
Operating income decreased 38.8%
Operating income changed -38.8% from the comparable as-filed period.
$16.3M→$10.0M2 prior comparisons
Net income decreased 43.6%
Net income changed -43.6% from the comparable as-filed period.
$12.6M→$7.1M2 prior comparisons
Free-cash-flow margin moved 791 bp lower
Free-cash-flow margin changed -791 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
16.24%→8.33%2 prior comparisons
Operating cash-flow margin moved 791 bp lower
Operating cash-flow margin changed -791 basis points from the comparable as-filed period.
16.41%→8.50%2 prior comparisons
Revenue increased 0.8%
Revenue changed +0.8% from the comparable as-filed period.
$212.0M→$213.7M2 prior comparisons
Current liabilities decreased 3.6%
Current liabilities changed -3.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$493.9M→$476.0M4 prior comparisons
Capex / revenue moved 0 bp higher
Capex / revenue changed +0 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.17%→0.17%2 prior comparisons
Current assets decreased 3.5%
Current assets changed -3.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$767.2M→$740.2M4 prior comparisons
Total assets decreased 3.2%
Total assets changed -3.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.1B→$1.1B4 prior comparisons
Research & development increased 5.5%
Research & development changed +5.5% from the comparable as-filed period.
$23.2M→$24.4M2 prior comparisons
Gross profit decreased 3.7%
Gross profit changed -3.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$144.6M→$139.2M2 prior comparisons
Working capital decreased 3.3%
Working capital changed -3.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$273.3M→$264.2M4 prior comparisons
R&D / revenue moved 51 bp higher
R&D / revenue changed +51 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
10.92%→11.43%2 prior comparisons
SBC / revenue moved 50 bp lower
SBC / revenue changed -50 basis points from the comparable as-filed period.
10.05%→9.55%2 prior comparisons
Stock-based compensation decreased 4.2%
Stock-based compensation changed -4.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$21.3M→$20.4M2 prior comparisons
Current ratio increased 0.1%
Current ratio changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
1.55→1.564 prior comparisons
Operating cash flow / net income decreased 7.4%
Operating cash flow / net income changed -7.4% from the comparable as-filed period.
2.76→2.552 prior comparisons
Working capital / assets moved 4 bp lower
Working capital / assets changed -4 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
25.16%→25.12%4 prior comparisons
Capital expenditure increased 2.2%
Capital expenditure changed +2.2% from the comparable as-filed period.
$365,000→$373,0003 prior comparisons
Gross margin moved 435 bp lower
Gross margin changed -435 basis points from the comparable as-filed period.
69.52%→65.17%3 prior comparisons
Operating margin moved 569 bp higher
Operating margin changed +569 basis points from the comparable as-filed period.
-0.85%→4.83%3 prior comparisons
Free-cash-flow proxy decreased 16.1%
Free-cash-flow proxy changed -16.1% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
$83.5M→$70.0M6 prior comparisons
Operating cash flow decreased 16.0%
Operating cash flow changed -16.0% from the comparable as-filed period. The change ranks at the 17th percentile of 6 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
$83.8M→$70.4M6 prior comparisons
Cash & equivalents increased 29.2%
Cash & equivalents changed +29.2% from the comparable as-filed period.
$126.4M→$163.3M2 prior comparisons
Operating income changed across a sign change
Operating income changed +704.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$1.8M→$10.6M3 prior comparisons
Revenue increased 6.8%
Revenue changed +6.8% from the comparable as-filed period.
$205.5M→$219.5M3 prior comparisons
Capital expenditure increased 13.5%
Capital expenditure changed +13.5% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
$289,000→$328,0006 prior comparisons
Net income changed across a sign change
Net income changed +366.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$1.6M→$4.2M3 prior comparisons
SBC / revenue moved 124 bp lower
SBC / revenue changed -124 basis points from the comparable as-filed period.
10.36%→9.11%3 prior comparisons
Capex / revenue moved 1 bp higher
Capex / revenue changed +1 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.14%→0.15%2 prior comparisons
Stock-based compensation decreased 6.0%
Stock-based compensation changed -6.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$21.3M→$20.0M3 prior comparisons
Research & development increased 2.4%
Research & development changed +2.4% from the comparable as-filed period.
$22.8M→$23.4M3 prior comparisons
Gross profit increased 0.1%
Gross profit changed +0.1% from the comparable as-filed period.
$142.9M→$143.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.